Journal of Neurology

Article	Citations
A real-world study on the utility of regular rituximab treatment for neuromyelitis optica spectrum disorder	154
Prevalence of infratentorial superficial siderosis in a large general population sample from the UK Biobank	110
The deltoid muscle and the pattern of paresis in ALS	108
Tau levels in platelets isolated from Huntington’s disease patients serve as a biomarker of disease severity	104
A role for the Epstein–Barr virus in multiple sclerosis aetiology?	94
Pallidal deep brain stimulation for patients with myoclonus-dystonia without SGCE mutations	94
Richard Caton (1842-1926)	93
CSF biomarkers of B-cell activation in multiple sclerosis: a clinical perspective	85
Long-term outcome after decompressive hemicraniectomy for malignant middle cerebral artery infarction	83
Microstructural characterization of multiple sclerosis lesion phenotypes using multiparametric longitudinal analysis	82
Neuromyelitis optica spectrum disorder with a familial Mediterranean fever gene E84K mutation	78
Tacrolimus-induced Parkinsonism	77
Explaining recovery from coma with multimodal neuroimaging	77
Interpretable deep learning survival predictions in sporadic Creutzfeldt–Jakob disease	68
Different patterns of acute saccadic response to levodopa in de novo Parkinson’s disease	63
Reversible cerebral vasoconstriction syndrome after intravenous iron substitution: a case report	61
Epileptic disorders in Becker and Duchenne muscular dystrophies: a systematic review and meta-analysis	60
Phenotype-driven reanalysis reveals five novel pathogenic variants in 40 exome-negative families with Charcot–Marie–Tooth Disease	59
Neurological manifestation of HEV infection: still a rare disease entity?	59
Brain 18F-FDG PET findings and sequential vestibular testing in SCA27B: a case report	56
Correction to: Synergistic effects of vagus nerve stimulation and antiseizure medication	55
The DeMyers: Marian (1922–2012) and William (1924–2008)	53
Halting progressive multifocal leukoencephalopathy with pembrolizumab: the case of a patient with multiple sclerosis under fingolimod	53
Risk of secondary progression in patients with highly active multiple sclerosis treated with natalizumab: a real-life study	52
Radiation-induced intracranial vasculitis on high-resolution vessel wall MRI	51

Brain network topology and future development of freezing of gait in Parkinson’s disease: a longitudinal study	50
Correction to: Late‑onset Huntington’s disease associated with CAG repeat lengths of 30 and 31	48
Sensory neuropathy due to RFC1 in a patient with ALS: more than a coincidence?	48
Does visuospatial motion perception correlate with coexisting movement disorders in Parkinson’s disease?	48
SARA captures disparate progression and responsiveness in spinocerebellar ataxias	47
Response to SARS-CoV-2 vaccination in multiple sclerosis patients on disease modifying therapies	46
Historical and current issues in HIV encephalitis, and the role of neuropathology in HIV disease: a pathological perspective	46
Correction to: Epilepsy related multimorbidity, polypharmacy and risks in adults with intellectual disabilities: a national study	46
Neural correlates of dual-task walking in people with central neurological disorders: a systematic review	45
Assessment of cognitive function, structural brain changes and fatigue 6 months after treatment of neuroborreliosis	45
Stroke frequency, associated factors, and clinical features in primary systemic vasculitis: a multicentric observational study	45
Analysis of C9orf72 repeat length in progressive supranuclear palsy, corticobasal syndrome, corticobasal degeneration, and atypical parkinsonism	44
Natalizumab-induced pneumonitis	44
Humoral response after accelerated schedule of HBV vaccination in MS patients before anti-CD20 therapy	44
A decision aid is not the quick fix for improving shared decision-making in advanced Parkinson’s disease: results of a mixed methods feasibility study	44
Exploring epigenetic modifications as potential biomarkers and therapeutic targets in amyotrophic lateral sclerosis	44
International survey on the implementation of the European and American guidelines on disorders of consciousness	44
TS-HDS autoantibody: clinical characterization and utility from real-world tertiary care center experience	43
Primary progressive aphasia: six questions in search of an answer	42
Recent applications of quantitative electroencephalography in adult intensive care units: a comprehensive review	42
Hashimoto’s encephalopathy with diffuse leukoencephalopathy: serial MRI and gait analysis	41
Tourette syndrome: effects of acetyl-leucine in two individuals	41
Genetic forms of tauopathies: inherited causes and implications of Alzheimer’s disease-like TAU pathology in primary and secondary tauopathies	40
Dopaminergic responsiveness and dopaminergic challenge tests of Parkinson’s disease: a systematic review and meta-analysis	40
Acute symptomatic seizures and hippocampal sclerosis: the major contributor for post-stroke epilepsy?	39
Increased aneurysm wall permeability colocalized with low wall shear stress in unruptured saccular intracranial aneurysm	39
Longitudinal predictors of health-related quality of life in isolated dystonia	39
Complications of reversible cerebral vasoconstriction syndrome in relation to age	38
Eye tracking identifies biomarkers in α-synucleinopathies versus progressive supranuclear palsy	38
A retrospective study of autoimmune cerebellar ataxia over a 20-year period in a single institution	37
Dystonia management across Europe within ERN-RND: current state and future challenges	36
Keeping an eye on Parkinson’s disease: color vision and outer retinal thickness as simple and non-invasive biomarkers	35
Long-term efficacy and safety of ravulizumab in adults with anti-acetylcholine receptor antibody-positive generalized myasthenia gravis: results from the phase 3 CHAMPION MG open-label extension	35
Walter Russell Brain (1895–1966)	35
Incidence of Guillain–Barré syndrome in Cuba before and during the Oropouche virus emergency, 2018–2024	35
Retreating migraine patients in the second year with monoclonal antibodies anti-CGRP pathway: the multicenter prospective cohort RE-DO study	34
Proposal of new diagnostic criteria for fatal familial insomnia	34
Audiovisual analysis of the diagnostic video polysomnography in patients with isolated REM sleep behavior disorder	34
Genetic modifiers of upper limb function in Duchenne muscular dystrophy	34
eHealth tools to assess the neurological function for research, in absence of the neurologist: a systematic review, part II (hardware)	34
Endolymphatic space is age-dependent	34
Adult-onset mitochondrial movement disorders: a national picture from the Italian Network	33
Procedural and Clinical Outcome of Stroke after thrombectomy according to etiology: results from a nationwide registry	33
Longitudinal analysis and treatment of neuropsychiatric symptoms in post-acute sequelae of COVID-19	33
The intersection of delirium and long-term cognition in older adults: the critical role of delirium prevention	33
Impulse control and correlation to dopamine agonist serum concentrations in people with Parkinson's disease	33
Architecture and anatomy of executive processes: evidence from verbal fluency and Trail Making Test in 2009 stroke patients	33
The clinical phenotype of psychiatric-onset prodromal dementia with Lewy bodies: a scoping review	32
Cavernomas: to treat or not to treat?	31
Sutton’s law applies to functional neurology	31

Cost effectiveness of different treatment strategies with natalizumab for pregnant women with multiple sclerosis	31
Quantitative brainstem and spinal MRI in amyotrophic lateral sclerosis: implications for predicting noninvasive ventilation needs	31
Off-label-dosing of non-vitamin K-dependent oral antagonists in AF patients before and after stroke: results of the prospective multicenter Berlin Atrial Fibrillation Registry	31
Challenges in multinational rare disease clinical studies during COVID-19: regulatory assessment of cipaglucosidase alfa plus miglustat in adults with late-onset Pompe disease	31
Anti-SOX1 antibody-associated acute hemorrhagic leukoencephalitis	31
Estimation of ataxia severity in children with ataxia-telangiectasia using ankle-worn sensors	30
Neurophysiological and behavioural correlates of ocrelizumab therapy on manual dexterity in patients with primary progressive multiple sclerosis	30
Characterisation of RT-QuIC negative cases from the UK National CJD Research and Surveillance programme	29
Frontotemporal neurofibrillary tangles and cerebrovascular lesions are associated with autism spectrum behaviors in late-life dementia	29
Inflammatory neuropathy with evidence of anti-GQ1b antibodies in angioimmunoblastic T cell lymphoma (AITL): a case report	29
Cerebral infarctions following an increase in corticosteroids: an atypical case of reversible cerebral vasoconstriction syndrome	29
The complex relationship between antibody titers and clinical outcome in botulinum toxin type A long-term treated patients with cervical dystonia	29
Long-term clinical outcomes in patients with CIS treated with interferon beta-1b: results from the 15-year follow up of the BENEFIT trial	28
Health-related quality of life in Japanese patients with multiple sclerosis	28
Is there a spinal tap responder in progressive supranuclear palsy? The first prospective study	28
Left- vs right-sided migraine: a scoping review	28
Quantification of saccadic fatigability and diagnostic efficacy for myasthenia gravis	28
Translocator protein (TSPO)-PET as diagnostic and monitoring tool in COVID-19 related MRI-negative brainstem encephalitis: a case report	28
Regional distribution of polymorphisms associated to the disease-causing gene of spinocerebellar ataxia type 3	27
The role of serum neurofilament light (sNfL) as a biomarker in multiple sclerosis: insights from a systematic review	27
Longitudinal qualitative assessment of meaningful symptoms and relevance of WATCH-PD digital measures for people with early Parkinson’s	27
Episodic symptoms caused by neurovascular conflict of vagus nerve due to hemilateral anterior inferior cerebellar artery	27
Systematic review and evidence gap mapping of biomarkers associated with neurological manifestations in patients with COVID-19	27
Aphasia as a stroke mimic in older adults: a diagnostic challenge	27
Amyotrophic lateral sclerosis stratification: unveiling patterns with virome, inflammation, and metabolism molecules	27
Detection of patent foramen ovale in patients with ischemic stroke on prospective ECG-gated cardiac CT compared to transthoracic echocardiography	27
A novel prediction score determining individual clinical outcome 3 months after juvenile stroke (PREDICT-score)	27
Vestibular function testing in patients with RFC1 mutations	27
Mismatch between clinically defined classification of ALS stage and the burden of cerebral pathology	27
The frequency of non-motor symptoms in SCA3 and their association with disease severity and lifestyle factors	27
Smoking, obesity, and disability worsening in PPMS: an analysis of the INFORMS original trial dataset	26
Analyzing the relationship between specific brain structural changes and the diffusion tensor image analysis along the perivascular space index in idiopathic normal pressure hydrocephalus	26
Machine learning for adaptive deep brain stimulation in Parkinson’s disease: closing the loop	26
Encephalitis in HIV-infected adults in the antiretroviral therapy era	26
The impact of device-assisted therapies on the gut microbiome in Parkinson’s disease	26
Correction: Pharmacogenomics of clinical response to Natalizumab in multiple sclerosis: a genome-wide multi-centric association study	26
Air pollution, greenspace exposure and risk of Parkinson's disease: a prospective study of 441,462 participants	26
Neurological update: structural and functional imaging in epilepsy surgery	25
Ultra-late response (> 24 weeks) to anti-CGRP monoclonal antibodies in migraine: a multicenter, prospective, observational study	25
Relapses during treatment with monoclonal antibodies targeting B-cells in NMOSD	25
Progression independent of relapse activity in relapsing multiple sclerosis: impact and relationship with secondary progression	25
Anxiety and depression in Charcot-Marie-Tooth disease: data from the Italian CMT national registry	25
Outcome predictors of post-COVID conditions in the European Academy of Neurology COVID-19 registry	25
Risdiplam improves subjective swallowing quality in non-ambulatory adult patients with 5q-spinal muscular atrophy despite advanced motor impairment	25
The topography of infratentorial lesions in depression and anxiety in multiple sclerosis	25
The role of language-related functional brain regions and white matter tracts in network plasticity of post-stroke aphasia	25
Effectiveness of rituximab vs. ocrelizumab for the treatment of primary progressive multiple sclerosis: a real-world observational study	25
Novel biomarkers and neuroimaging techniques in Parkinson’s disease	24
MRI-guided focused ultrasound: new hope for drug-resistant neurological conditions	24
Present and future of the diagnostic work-up of multiple sclerosis: the imaging perspective	24
Associations of sleep disorders with cerebrospinal fluid α-synuclein in prodromal and early Parkinson’s disease	24
Dysregulation of the molecular clock by blood-borne factors in Alzheimer’s disease patients	24
Diaschisis: a mechanism for subcortical aphasia?	24
Artificial intelligence in neurology: opportunities, challenges, and policy implications	24
Intake reminders are effective in enhancing adherence to direct oral anticoagulants in stroke patients: a randomised cross-over trial (MAAESTRO study)	23
Natural history of facioscapulohumeral muscular dystrophy evaluated by multiparametric quantitative MRI: a prospective cohort study	23
Effect of siponimod on lymphocyte subsets in active secondary progressive multiple sclerosis and clinical implications	23
The correlation between 9-HPT and patient-reported measures of upper limb function in multiple sclerosis: a systematic review and meta-analysis	23
Impact of COVID-19 pandemic on frequency of clinical visits, performance of MRI studies, and therapeutic choices in a multiple sclerosis referral centre	23
Correlation between cognitive changes and neuroradiological changes over time in multiple sclerosis: a systematic review and meta-analysis	23
A new genetic cause of spastic ataxia: the p.Glu415Lys variant in TUBA4A	23
Rate of change in upper and lower motor neuron burden is associated with survival in amyotrophic lateral sclerosis	23
Beneficial effect of N-acetyl-DL-leucine on cognitive function, emotional well-being and QoL in a mentally healthy elderly person	22
Measuring cognitive impairment and monitoring cognitive decline in Huntington’s disease: a comparison of assessment instruments	22
Recurrence and long-term outcomes of Tolosa-Hunt syndrome	22
A perspective on persistent toxicants in veterans and amyotrophic lateral sclerosis: identifying exposures determining higher ALS risk	22
Genetic risk factors of Alzheimer’s Disease disrupt resting-state functional connectivity in cognitively intact young individuals	22
Measuring the functional impact of cognitive impairment in Huntington’s disease	22
Ocular phenotype and electroretinogram abnormalities in Lafora disease and correlation with disease stage	22
Distal hereditary motor neuronopathy as a new phenotype associated with variants in BAG3	22
Emerging technologies for management of patients with amyotrophic lateral sclerosis: from telehealth to assistive robotics and neural interfaces	22
Precision diagnosis and precision treatment for the genetic epilepsies	22
How to identify insular epilepsy	22
Rho GTPase-activating protein 10 (ARHGAP10/GRAF2) is a novel autoantibody target in patients with autoimmune encephalitis	22
Efficacy and safety of adjunctive perampanel treatment in pediatric patients with epilepsy aged 4–12 years: a real-world study	21
Locus coeruleus degeneration and cerebellar gray matter changes in essential tremor	21
Loss of brainstem white matter predicts onset and motor neuron symptoms in C9orf72 expansion carriers: a GENFI study	21
Fingolimod-associated progressive multifocal leukoencephalopathy in a multiple sclerosis patient with a good response to filgrastim	21
Correction: Metabolomic profile of cerebrospinal fluid from patients with diffuse gliomas	21
Measurement of upper limb function in ALS: a structured review of current methods and future directions	21

The impact of the SARS-CoV-2-pandemic on patients with chronic inflammatory neuropathies: results from the German INHIBIT register	21
Evaluation of drivers of treatment switch in relapsing multiple sclerosis: a study from the Italian MS Registry	21
Frida Kahlo could have had cauda equina syndrome: a case report	21
Parkinson’s disease with hyposmia and dysautonomia: does it represent a distinct subtype?	21
Modulation of spontaneous motor unit potentials by a new motor cortical magnetic stimulation method in amyotrophic lateral sclerosis	21
Different approaches to test orientation of self in space: comparison of a 2D pen-and-paper test and a 3D real-world pointing task	21
Diagnostic accuracy and usability of the EMBalance decision support system for vestibular disorders in primary care: proof of concept randomised controlled study results	21
Visual quality of life in NMOSD and MOGAD: profiles, dynamics and associations with ageing and vision	21
Bilateral vestibulopathy decreases self-motion perception	21
Paroxysmal central positional nystagmus responsive to clonazepam	20
The value of magnetic resonance imaging of the optic nerve for the diagnosis of multiple sclerosis in patients with optic neuritis	20
Diagnostic accuracy and confounders of vagus nerve ultrasound in amyotrophic lateral sclerosis—a single-center case series and pooled individual patient data meta-analysis	20
Early use of high-efficacy therapies in multiple sclerosis in the United States: benefits, barriers, and strategies for encouraging adoption	20
Specific clinical and radiological characteristics of anti-NMDA receptor autoimmune encephalitis following herpes encephalitis	20
Unprescribed cannabinoids and multiple sclerosis: a multicenter, cross-sectional, epidemiological study in Lombardy, Italy	20
Usefulness of subcutaneous immunoglobulin therapy in the management of myasthenia gravis: a retrospective cohort study	20
Fluctuations in serum aquaporin-4 antibody titers: the clinical significance in neuromyelitis optica spectrum disorder	20
Diagnosing primary lateral sclerosis: a clinico-pathological study	20
Effectiveness of endovascular treatment for in-hospital stroke vs. community-onset stroke: a propensity score-matched analysis	20
Effectiveness and safety of pharmacological prophylaxis for chronic migraine: a systematic review and network meta-analysis	20
Sleep-disordered breathing-related symptoms and risk of stroke: cohort study and Mendelian randomization analysis	20
Motor and non-motor outcome in tremor dominant Parkinson’s disease after MR-guided focused ultrasound thalamotomy	20
Muscle MRI as a biomarker of disease activity and progression in myotonic dystrophy type 1: a longitudinal study	20
Retinal thickness as a biomarker of cognitive impairment in manifest Huntington’s disease	20
Occurrence of area postrema syndrome during follow-up: phenotype and influence over NMOSD activity in LATAM in real-world settings	20
The effects of dopaminergic medication and task load on trembling and akinetic freezing of gait in Parkinson’s disease	19
Spinocerebellar ataxia 27B: a frequent and slowly progressive autosomal-dominant cerebellar ataxia—experience from an Italian cohort	19
Systematic assessment of square-wave jerks in progressive supranuclear palsy: a video-oculographic study	19
Subjective and objective responses to caloric stimulation help separate vestibular migraine from other vestibular disorders	19
Impacts of medication non-adherence to major modifiable stroke-related diseases on stroke prevention and mortality: a meta-analysis	19
Association of rare variants in genes of immune regulation with pediatric autoimmune CNS diseases	19
Exploring the impact of 40 Hz multi-luminaire light exposure in Alzheimer's dementia: insights from a convenient sampling, non-randomized case–control study	19
Isolated REM sleep behaviour disorder: current diagnostic procedures and emerging new technologies	19
Quantitative whole-body muscle MRI in idiopathic inflammatory myopathies including polymyositis with mitochondrial pathology: indications for a disease spectrum	19
Overcoming traps and pitfalls leading to misinterpretation of normal EEG variants and variation of the background activity	19
Incidence of cerebral small vessel disease-related MR markers in the Swedish general population ‘Good Aging in Skåne’(GÅS) study	19
Frequency and predictors of poststroke epilepsy after mechanical thrombectomy for large vessel occlusion stroke: results from a multicenter cohort study	19
The impact of spontaneous intracranial hypotension on social life and health-related quality of life	19
Effects of motor–cognitive training on dual-task performance in people with Parkinson’s disease: a systematic review and meta-analysis	19
Burden of disease in myasthenia gravis: taking the patient’s perspective	19
Photophobia in headache disorders: characteristics and potential mechanisms	19
The impact of an MSU service on acute stroke care in a middle-sized city: a simulation-based analysis	18
A disproportionality analysis of surgical site infections across multiple sclerosis disease modifying therapies	18
Understanding social media: how its popularity could be used to advance medical education in stroke care?	18
Upper motor neuron-predominant motor neuron disease: a novel immunotherapy-responsive association of GAD65 autoimmunity	18
Correction to: Off-label-dosing of non-vitamin K-dependent oral antagonists in AF patients before and after stroke: results of the prospective multicenter Berlin Atrial Fibrillation Registry	18
Correction to: DRPLA: understanding the natural history and developing biomarkers to accelerate therapeutic trials in a globally rare repeat expansion disorder	18
Louis Jacobsohn-Lask (1863–1940)	18
Diagnostic utility of neurofilament markers for MND is limited in restricted disease phenotype and for differentiation from compressive myeloradiculopathies	18
COVID-19 infection after SARS-CoV-2 mRNA vaccination in Multiple Sclerosis, AQP4-antibody NMOSD and MOGAD patients during the Omicron subvariant BA.1/2 wave in Singapore	18
Optic neuritis and MOGAD	18
Epileptogenicity of white matter lesions in cerebral small vessel disease: a systematic review and meta-analysis	18
Good vibrations: tactile cueing for freezing of gait in Parkinson’s disease	18
Correction to: Outcomes of mechanical thrombectomy in patients with acute ischemic stroke and thrombocytopenia: systematic review and meta-analysis	18
The phenotypic spectrum of epilepsy associated with periventricular nodular heterotopia	18
(William) Ritchie Russell (1903–1980)	18
Motor function in multiple sclerosis assessed by navigated transcranial magnetic stimulation mapping	18
Leg stereotypy syndrome: phenomenological and quantitative analysis	18
Stroke in adults with primary intracranial tumours	18
The effect and safety of levodopa alone versus levodopa sparing therapy for early Parkinson’s disease: a systematic review and meta-analysis	18
Brain positron emission tomography (PET) and cognitive abnormalities one year after COVID-19	18
Dopamine transporter single photon emission computed tomography (DaT-SPECT) use in the diagnosis and clinical management of parkinsonism: an 8-year retrospective study	18
Cognition in cerebellar disorders: What’s in the profile? A systematic review and meta-analysis	18
Cerebral mucormycosis: neuroimaging findings and histopathological correlation	18
A survey-based approach on restless legs syndrome: practices and perspectives among Italian neurologists	18
A rare case of a wall-eyed bilateral internuclear ophthalmoplegia (WEBINO) syndrome in a patient with cutaneous lupus erythematosus after COVID-19 infection	18
Movement disorders in autoimmune encephalitis: an update	17
Time course of lesion-induced atrophy in multiple sclerosis	17
Radiologically isolated syndromes: to treat or not to treat?	17
Resurrection of sildenafil: potential for Huntington’s Disease, too?	17
Case report: cerebral sinus vein thrombosis in two patients with AstraZeneca SARS-CoV-2 vaccination	17
Pathological findings in autoimmune encephalitis autopsy specimens from cases of suspected prion disease	17
NMOSD typical brain lesions after COVID-19 mRNA vaccination	17
The impact of subthalamic deep-brain stimulation in restoring motor symmetry in Parkinson’s disease patients: a prospective study	17
Frataxin analysis using triple quadrupole mass spectrometry: application to a large heterogeneous clinical cohort	17
Comprehensive pathological and genetic investigation of three young adult myotonic dystrophy type 1 patients with sudden unexpected death	17
Conjugate torsional pendular nystagmus and palatal tremor after unilateral internuclear ophthalmoplegia	17
A score to predict the stroke recurrence of patients with embolic stroke of undetermined source	17
Volumetric changes and clinical trajectories in Parkinson’s disease: a prospective multicentric study	17
Clinical and imaging spectrum of non-congenital dominant ACTN2 myopathy	17
Morning light therapy in adults with Tourette’s disorder	16
Characteristics of HHV-7 meningitis: a systematic review	16
Strong diagnostic performance of plasma ptau217 for CSF biomarker-defined young-onset Alzheimer disease in a diagnostically heterogeneous clinical cohort	16
Abuse and revictimization in adulthood in multiple sclerosis: a cross-sectional study during pregnancy	16
Olfactory dysfunction is common in classical infratentorial superficial siderosis of the central nervous system	16
Comparison of clinical features in patients with vestibular migraine and migraine	16
Cognitive disorders in childhood epilepsy: a comparative longitudinal study using administrative healthcare data	16
Difference in safety and humoral response to mRNA SARS-CoV-2 vaccines in patients with autoimmune neurological disorders: the ANCOVAX study	16
Endovascular thrombectomy with or without intravenous alteplase in acute stroke: a systematic review and meta-analysis of randomized clinical trials	16
Chimeric antigen receptor T-cell therapy for autoimmune diseases of the central nervous system: a systematic literature review	16
Assessing initial MRI reports for suspected CJD patients	16
Combined central and peripheral demyelination after COVID-19 vaccination	16
Myasthenia gravis, respiratory function, and respiratory tract disease	16
The impact of metformin use on the outcomes of relapse-remitting multiple sclerosis patients receiving interferon beta 1a: an exploratory prospective phase II open-label randomized controlled trial	16
NFL and GFAP in (pre)symptomatic RVCL-S carriers: a monogenic cerebral small vessel disease	16